N Giacomi

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Sandra M. Swain, David Miles, Sung‐Bae Kim et al. · The Lancet Oncology · 2020 · 898 citations

Medicine, Oncology, Pharmacology +14

Immunohistochemical expression of somatostatin receptors in digestive endocrine tumours

Víctor Zamora, Ana Cabanne, Rubén Salanova et al. · Digestive and Liver Disease · 2009 · 73 citations

Medicine, Oncology, Pathology +13

Observational study of patients with gastroenteropancreatic and bronchial neuroendocrine tumors in Argentina: Results from the large database of a multidisciplinary group clinical multicenter study

Juan Manuel O’Connor, F. Marmissolle, Claudia Bestani et al. · Molecular and Clinical Oncology · 2014 · 65 citations · Full text

Medicine, Oncology, Pathology +15

Chromogranin A as a biochemical marker for the management of neuroendocrine tumors: a multicenter study developed in Argentina.

Susana Belli, Adriana Oneto, Claudio Aranda et al. · PubMed · 2009 · 19 citations

Medicine, Endocrinology, Oncology +16

Report of solid cancer in patients (pts) with gastrointestinal stromal tumours (GIST)

Matías Chacón, Enrique Roca, Mario Barugel et al. · Journal of Clinical Oncology · 2004 · 13 citations

Medicine, Oncology, Gastrointestinal Oncology +4